Supporting the designation of May as "National Myositis Awareness Month".

Richard McCormick

Republican · GA · Representative

Source: Congress.gov · FEC

• Paul Tonko (D-NY-20)· 2026-04-28
• Sarah Elfreth (D-MD-3)· 2026-04-30

Referred to the House Committee on Energy and Commerce.

2026-04-20

Source: Congress.gov

This resolution would officially designate May as "National Myositis Awareness Month" to help raise public attention about myositis, a group of rare diseases that cause muscle inflammation and weakness. The designation would encourage healthcare providers, patient advocacy groups, and the public to learn more about these conditions and support those living with them. While the resolution itself doesn't create new programs or funding, it aims to increase awareness of diseases that affect a relatively small but vulnerable population.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H. Res. 1195 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. RES. 1195 Supporting the designation of May as ``National Myositis Awareness Month''. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES April 20, 2026 Mr. McCormick submitted the following resolution; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ RESOLUTION Supporting the designation of May as ``National Myositis Awareness Month''. Whereas residents of the United States of America are among those affected by myositis and other rare diseases, with nearly 1 in 10 Americans having rare diseases; Whereas idiopathic inflammatory myopathies (collectively referred to as myositis) are rare, chronic, autoimmune muscle-wasting diseases that often feature debilitating muscle inflammation and other symptoms, such as pain, fatigue, and trouble swallowing, and can result in myositis- associated interstitial lung disease; Whereas more research is needed to identify the causes of and modes of treatments for the myositis group of diseases, which includes anti-MDA5 autoantibody-positive myositis, antisynthetase syndrome, dermatomyositis, juvenile dermatomyositis, immune-mediated necrotizing myopathy, inclusion body myositis, and polymyositis; Whereas myositis is difficult to diagnose which leads myositis patients to frequently experience delayed treatment and difficulty finding a health care provider with expertise in their condition; Whereas all who suffer with myositis experience reduced quality of life, particularly since no cure has been found and life expectancy is shortened, especially for those with inclusion body myositis; and Whereas public awareness and education campaigns on myositis detection and treatment are held during the month of May: Now, therefore, be it Resolved, That the House of Representatives-- (1) supports the designation of ``National Myositis Awareness Month''; (2) recognizes the importance of raising awareness about myositis and its impact on United States veterans and citizens; and (3) encourages all people in the United States to become more informed about myositis and to support the individuals and families who are affected by these conditions. <all>

• HR9755To establishes a new position of Senior Biotechnology Official within the Department of State to enhance United States leadership in global biotechnology challenges by leading United States efforts in biotechnology diplomacy, security, and innovation, and for other purposes.
  Referred to Committee · 2026-07-16
• HR8938Biotechnology Workforce Alignment Act of 2026
  Referred to Committee · 2026-05-20
• HR8580Forestry Protection Act of 2026
  Referred to Committee · 2026-04-29
• HR7962Export Dispute Resolution Act
  Reported by Committee · 2026-04-22